Clinical trial
Galantamine Augmentation of Escitalopram for Treatment of Depression
NCT00423969 · Indiana University School of Medicine, Other · Terminated
Key facts
| NCT number | NCT00423969 |
|---|---|
| Title | Galantamine Augmentation of Escitalopram for Treatment of Depression |
| Official title | Galantamine Augmentation of Escitalopram for Treatment of Depression Associated Cognitive Impairment in Outpatients - A Randomized Single Blind Clinical Trial |
| Lead sponsor | Indiana University School of Medicine, Other |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Depression |
| Intervention type | Drug |
| Interventions | Galantamine, Escitalopram |
| Enrollment | 20 |
| Start date | Nov 1, 2003 |
| Completion | Sep 1, 2005 |
| First posted | Jan 18, 2007 |
| Last update posted | Jan 18, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: